Table 2.
Demographics and treatment-related factors by SF-36 physical (PCS) and mental (MCS) component scores at 6 months post-transplant
N=106a | SF-36 PCS at 6 months |
SF-36 MCS at 6 months |
||||
---|---|---|---|---|---|---|
Characteristic | PCS >40 34(32%) N(%) |
PCS ≤40 72(68%) N(%) |
P value | MCS >40 80(75%) N(%) |
MCS ≤40 26(25%) N(%) |
P value |
Age at transplant, years | ||||||
<35 | 12(35) | 16(22) | 0.65 | 22(28) | 6(23) | 0.49 |
35–49 | 14(41) | 40(56) | 42(53) | 12(46) | ||
≥50 | 8(24) | 16(22) | 16(20) | 8(31) | ||
Female | 19(56) | 43(60) | 0.99 | 47(59) | 15(58) | 0.90 |
Education ≥4 years college | 20(59) | 31(43) | 0.25 | 33(41) | 18(69) | 0.03 |
Married | 21(59) | 51(71) | 0.23 | 53(66) | 18(69) | 0.86 |
Pre-transplant risk group | ||||||
Low | 19(56) | 26(36) | 0.12 | 34(43) | 11(42) | 0.65 |
Moderate | 12(35) | 29(40) | 30(38) | 11(42) | ||
High | 3(9) | 17(24) | 16(20) | 4(15) | ||
Total body irradiation | 21(62) | 35(49) | 0.42 | 44(55) | 12(46) | 0.37 |
Chronic graft-vs-host disease (GVHD)b | 18(53) | 48(67) | 0.22 | 48(60) | 18(69) | 0.51 |
Sample is comprised of the 106 HCT patients who had not returned to work and had not died or relapsed by 6 months post-HCT. An imputation prediction model generated SF-36 scores for 17 cases with missing PCS and MCS scores
Report of clinical extensive chronic GVHD onset at any point during the first 5 years after HCT